Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Ho

Showing results (151-160 of 221) with videos related to

Pageof 23
Sort By:
Lancet (London, England)|November 30, 1999
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresisB Ramratnam, S Bonhoeffer, J Binley, et al.
AIDS Research and Human Retroviruses|March 1, 1995
Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasmaY Cao, D D Ho, J Todd, et al.
Nature Medicine|December 29, 1999
The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapyB Ramratnam, J E Mittler, L Zhang, et al.
DNA (Mary Ann Liebert, Inc.)|April 1, 1986
Human T-cell lymphotropic virus type III (HTLV-III) core antigens: synthesis in Escherichia coli and immunoreactivity with human seraJ Ghrayeb, I Kato, S McKinney, et al.
Journal of Virology|February 1, 1992
Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120M S Fung, C R Sun, W L Gordon, et al.
Immunology Letters|April 15, 1999
Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapyD F Nixon, D Douek, P J Kuebler, et al.
Journal of Acquired Immune Deficiency Syndromes|April 1, 1994
Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid-phase peptide binding assaysJ P Moore, Y Cao, A J Conley, et al.
AIDS Research and Human Retroviruses|May 1, 1995
Seroreactivity of analogous antigenic epitopes in glycoprotein 120 expressed in HIV-1 subtypes A, B, C, and DG A Pestano, K S Hosford, A I Spira, et al.
The Journal of Infectious Diseases|October 21, 1998
Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission. ARIEL Project InvestigatorsX Jin, C G Roberts, D F Nixon, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1995
Safety, pharmacokinetics, and antiviral activity of A77003, a C2 symmetry-based human immunodeficiency virus protease inhibitorM Reedijk, C A Boucher, T van Bommel, et al.
Pageof 23

Showing results (151-160 of 221) with videos related to

Sort By:
Pageof 23
Lancet (London, England)|November 30, 1999
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresisB Ramratnam, S Bonhoeffer, J Binley, et al.
AIDS Research and Human Retroviruses|March 1, 1995
Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasmaY Cao, D D Ho, J Todd, et al.
Nature Medicine|December 29, 1999
The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapyB Ramratnam, J E Mittler, L Zhang, et al.
DNA (Mary Ann Liebert, Inc.)|April 1, 1986
Human T-cell lymphotropic virus type III (HTLV-III) core antigens: synthesis in Escherichia coli and immunoreactivity with human seraJ Ghrayeb, I Kato, S McKinney, et al.
Journal of Virology|February 1, 1992
Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120M S Fung, C R Sun, W L Gordon, et al.
Immunology Letters|April 15, 1999
Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapyD F Nixon, D Douek, P J Kuebler, et al.
Journal of Acquired Immune Deficiency Syndromes|April 1, 1994
Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid-phase peptide binding assaysJ P Moore, Y Cao, A J Conley, et al.
AIDS Research and Human Retroviruses|May 1, 1995
Seroreactivity of analogous antigenic epitopes in glycoprotein 120 expressed in HIV-1 subtypes A, B, C, and DG A Pestano, K S Hosford, A I Spira, et al.
The Journal of Infectious Diseases|October 21, 1998
Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission. ARIEL Project InvestigatorsX Jin, C G Roberts, D F Nixon, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1995
Safety, pharmacokinetics, and antiviral activity of A77003, a C2 symmetry-based human immunodeficiency virus protease inhibitorM Reedijk, C A Boucher, T van Bommel, et al.
Pageof 23